코카인 중독 특이적 바이오 마커

    公开(公告)号:KR102208012B1

    公开(公告)日:2021-01-27

    申请号:KR1020170176088

    申请日:2017-12-20

    Abstract: 본발명은코카인의급성또는만성투여시발현이유의적으로변화하는바이오마커들에관한것으로, 본발명의바이오마커인 ARHGEF7, PTOV1, GTF2I, ADAM23, CDH2, GRIA1 (GRIA1X3, GRIA1X4), GRIA2 (GRIA2X6, GRIA2X7), HDAC5, HDAC10, NCAM1, NPY, SNCA, CCNG2, CDC7, CDH8, DLG3, DOCK3, NEUROD6, NEUROG2, SPEN, KDM2B (KDM2BX10, KDM2BX13), KIFAP3, RBM10, RBM14, TP53I11, WNT10B, MCM3AP, DRD1, DRD2, DRD3, GNAL, GNG7, LOC101865389, LOC101926461, PPP2R2B, ACHE, ADCY5, AKT3, KCNJ2, LOC101865389, LOC101926461, PLCB1, SLC18A3, SLC5A7, CAMK2A, EGLN2, ENO2, LOC101866179, LOC101866246, BAD, BCL2L1, CASP9, LOC101925175 및 TNFRSF1A는코카인의급성또는만성투여시 mRNA 및단백질의발현량이유의적으로상향또는하향조절되므로, 이들의발현패턴을통해코카인의급성또는만성노출에의한코카인중독및 의존성을확인할수 있다.

Patent Agency Ranking